Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypercytokinemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03557749
What this trial is testing

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Who this might be right for
Immune and Microbial ReconstitutionSystemic Viral InfectionAcute-graft-versus-host Disease+5 more
Masonic Cancer Center, University of Minnesota 210
Early research (Phase 1)Active Not RecruitingNCT03016377
What this trial is testing

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Who this might be right for
Acute Lymphoblastic LeukemiaImmune System DiseasesImmunoproliferative Disorders
UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Not applicableUnknownNCT04486521
What this trial is testing

Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19

Who this might be right for
Critical IllnessCorona Virus InfectionCytokine Release Syndrome
King Faisal Specialist Hospital & Research Center 860
Large-scale testing (Phase 3)UnknownNCT04386850
What this trial is testing

Oral 25-hydroxyvitamin D3 and COVID-19

Who this might be right for
COVID 19
Tehran University of Medical Sciences 1,500
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Not applicableUnknownNCT03786991
What this trial is testing

EPI-STORM: Cytokine Storm in Organ Donors

Who this might be right for
Organ DonationLiver TransplantationKidney Transplantation+1 more
Université de Sherbrooke 105
Testing effectiveness (Phase 2)Study completedNCT04975555
What this trial is testing

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

Who this might be right for
Cytokine Release SyndromeICANSLymphoma, Non-Hodgkin+2 more
University of Alabama at Birmingham 20
Testing effectiveness (Phase 2)Study completedNCT04357860
What this trial is testing

Clinical Trial of Sarilumab in Adults With COVID-19

Who this might be right for
SARS-CoV 2SARS
Maimónides Biomedical Research Institute of Córdoba 120
Not applicableStudy completedNCT05476848
What this trial is testing

Relationship Between Oral Findings and Salivary Factors in Sars-Cov-2 Patients

Who this might be right for
Decay, DentalMissing TeethCOVID-19+1 more
Ege University 320
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Testing effectiveness (Phase 2)Study completedNCT06676709
What this trial is testing

Effect of IMMUNEPOTENT-CRP on Serum Pro-Inflammatory Cytokines in Mild to Moderate COVID-19

Who this might be right for
COVID-19SARS-CoV2 Infection
Universidad Autonoma de Nuevo Leon 80
Large-scale testing (Phase 3)Study completedNCT04362111
What this trial is testing

Early Treatment of Cytokine Storm Syndrome in Covid-19

Who this might be right for
Cytokine StormCOVID-19
University of Alabama at Birmingham 32
Testing effectiveness (Phase 2)UnknownNCT05656521
What this trial is testing

101-PGC-005 for the Treatment of COVID-19

Who this might be right for
COVID-19
101 Therapeutics 62
Testing effectiveness (Phase 2)Looking for participantsNCT07589634
What this trial is testing

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 230
Early research (Phase 1)Active Not RecruitingNCT05823571
What this trial is testing

Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients

Who this might be right for
Leukemia, AcuteMyelodysplastic SyndromesMyelomonocytic Leukemia, Chronic+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Not applicableUnknownNCT04598334
What this trial is testing

Cytokine Storm Among Bangladeshi Patients With COVID-19

Who this might be right for
Cytokine Storm, COVID-19
International Centre for Diarrhoeal Disease Research, Bangladesh 75
Not applicableUnknownNCT06491966
What this trial is testing

Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis

Who this might be right for
SepsisSepsis BacterialViral Sepsis+4 more
Sichuan Provincial People's Hospital 300
Large-scale testing (Phase 3)UnknownNCT04468646
What this trial is testing

To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients

Who this might be right for
Neurokinin 1 Receptor, Substance P, Respiratory Illness, Inflammation, Covid-19, Coronavirus
Prof. Dr. Fridoon Jawad Ahmad 100
Testing effectiveness (Phase 2)Ended earlyNCT04540120
What this trial is testing

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Who this might be right for
Covid19Cytokine Release Syndrome
Olatec Therapeutics, Inc. 49
Next Page